BETHLEHEM, Pa.—The U.S. Food and Drug Administration (FDA) has approved B. Braun Medical’s Introcan Safety 3 Closed IV Catheter.
The company's Introcan Safety 3 Closed IV Catheter, the next generation of B. Braun's Introcan Safety IV Catheter. B. Braun made the announcement during the Association for Vascular Access 2011 Annual Scientific Meeting in San Jose, Calif., in early October.
"Recent research confirms passive safety engineered devices are most effective for needlestick injury prevention," said Tom Sutton, Vice President, Vascular Access and IV Systems for B. Braun Medical Inc. "The Introcan Safety 3 is designed to provide clinicians with not only an effective passive needlestick safety device, but also an added layer of safety and control with a bidirectional blood control valve to aid in the prevention of blood exposure each time the device is accessed."
According to B. Braun, the Introcan Safety 3 provides protection through a Passive Safety Needle Shield to aid in the prevention of NSIs, multiple Access Blood Control Valve to aid in the prevention of blood exposure, and integrated Stabilization Platform to improve catheter stability and minimize movement within the vessel.
